Russell Katz appointed US Account Manager of m2p-labs, Inc.

New management will strengthen customer relations

(PresseBox) - In his new position as US Account Manager, Russell Katz takes over the operational and strategic responsibility for sales and service in North America and Canada. Mr. Katz has been working in the American biotechnology industry for many years and most recently held the position of Sales Manager of Eppendorf in the States.
Dr. Frank Kensy, Managing Director of m2p-labs, comments: "I am delighted to announce the appointment of Russ which demonstrates the strategic importance of the North America market as one of the key markets for m2p-labs. As experienced sales person with a background in biotechnology he has an excellent knowledge of the market and has already worked with a number of biotech companies."
"m2p-labs is a highly innovative biotechnology company offering screening systems for an efficient development of bioprocesses. With its unique technology microbial cells can be screened and controlled on micro scale and highly parallel." Mr. Katz explains.
For nearly ten years the company operates successfully in the European Life Science market and currently expands its leading technology position in the international markets. The subsidiary m2p-labs, Inc. was established in the US in January 2012 in order to be closer to its US clients. Mr. Katz will now be able to provide US customers with more efficient sales and service and to develop the market more effectively.

Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: PresseBox
Datum: 23.06.2014 - 12:52 Uhr
Sprache: Deutsch
News-ID 333235
Anzahl Zeichen: 1512

contact information:
Town:

Baesweiler/Germany

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 323 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Russell Katz appointed US Account Manager of m2p-labs, Inc."
steht unter der journalistisch-redaktionellen Verantwortung von

m2p-labs GmbH (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

New technologies for the highly parallel optimization of cell culture processes ...

The EU Commission and the ?European Federation of Pharmaceutical Industries and Associations? (EFPIA) will be funding another joint research project called iConsensus. The project has the aim of developing new scientific methods for the optimization ...

European patent granted to m2p-labs for microbioreactor device ...

The European Patent Office has granted a patent to m2p-labs of Baesweiler, Germany, for an innovative microbioreactor device to facilitate high-throughput bioprocess optimization in the life science market. 48 microbioreactors are placed on a standar ...

FIDURA Private Equity Fonds a new lead investor at m2p-labs ...

Founded in 2005, m2p-labs GmbH successfully closed its financing round with FIDURA Private Equity Fonds as a new lead investor. Through a capital increase with the participation of seed investors such as the High-Tech-Gründerfonds as the biggest co ...

Alle Meldungen von m2p-labs GmbH